134 related articles for article (PubMed ID: 20491773)
1. Polycomb group molecule PHC3 regulates polycomb complex composition and prognosis of osteosarcoma.
Iwata S; Takenobu H; Kageyama H; Koseki H; Ishii T; Nakazawa A; Tatezaki S; Nakagawara A; Kamijo T
Cancer Sci; 2010 Jul; 101(7):1646-52. PubMed ID: 20491773
[TBL] [Abstract][Full Text] [Related]
2. PHC3, a component of the hPRC-H complex, associates with E2F6 during G0 and is lost in osteosarcoma tumors.
Deshpande AM; Akunowicz JD; Reveles XT; Patel BB; Saria EA; Gorlick RG; Naylor SL; Leach RJ; Hansen MF
Oncogene; 2007 Mar; 26(12):1714-22. PubMed ID: 17001316
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-330-3p Expression Indicates Good Prognosis and Suppresses Cell Proliferation by Targeting Bmi-1 in Osteosarcoma.
Zheng Z; Bao F; Chen X; Huang H; Zhang X
Cell Physiol Biochem; 2018; 46(2):442-450. PubMed ID: 29614499
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of X-Box Binding Protein 1 (XBP1) Correlates to Poor Prognosis and Up-Regulation of PI3K/mTOR in Human Osteosarcoma.
Yang J; Cheng D; Zhou S; Zhu B; Hu T; Yang Q
Int J Mol Sci; 2015 Dec; 16(12):28635-46. PubMed ID: 26633383
[TBL] [Abstract][Full Text] [Related]
5. Reexpression of LSAMP inhibits tumor growth in a preclinical osteosarcoma model.
Barøy T; Kresse SH; Skårn M; Stabell M; Castro R; Lauvrak S; Llombart-Bosch A; Myklebost O; Meza-Zepeda LA
Mol Cancer; 2014 Apr; 13():93. PubMed ID: 24885297
[TBL] [Abstract][Full Text] [Related]
6. CBX2 is a functional target of miRNA let-7a and acts as a tumor promoter in osteosarcoma.
Han Q; Li C; Cao Y; Bao J; Li K; Song R; Chen X; Li J; Wu X
Cancer Med; 2019 Jul; 8(8):3981-3991. PubMed ID: 31150156
[TBL] [Abstract][Full Text] [Related]
7. MiR-363 suppresses cell migration, invasion, and epithelial-mesenchymal transition of osteosarcoma by binding to NOB1.
Zhang Y; Wang F; Wang L; Zhang Q
World J Surg Oncol; 2020 May; 18(1):83. PubMed ID: 32357945
[TBL] [Abstract][Full Text] [Related]
8. The knock-down of overexpressed EZH2 and BMI-1 does not prevent osteosarcoma growth.
Sasaki H; Setoguchi T; Matsunoshita Y; Gao H; Hirotsu M; Komiya S
Oncol Rep; 2010 Mar; 23(3):677-84. PubMed ID: 20127006
[TBL] [Abstract][Full Text] [Related]
9. TRIM2 regulates the development and metastasis of tumorous cells of osteosarcoma.
Qin Y; Ye J; Zhao F; Hu S; Wang S
Int J Oncol; 2018 Oct; 53(4):1643-1656. PubMed ID: 30066883
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of BMI-1 promotes cell growth and resistance to cisplatin treatment in osteosarcoma.
Wu Z; Min L; Chen D; Hao D; Duan Y; Qiu G; Wang Y
PLoS One; 2011 Feb; 6(2):e14648. PubMed ID: 21311599
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of microRNA-106a-5p-RUNX1 axis associates with clinical progression and prognosis of osteosarcoma patients.
Chen K; Pan G
Pathol Res Pract; 2019 Dec; 215(12):152686. PubMed ID: 31711673
[TBL] [Abstract][Full Text] [Related]
12. The role and clinical significance of long noncoding RNA zinc finger E-box-binding homeobox two antisense RNA 1 in promoting osteosarcoma cancer cell proliferation, inhibiting apoptosis and increasing migration by regulating miR-145.
Zhou Y; Feng D; Gu X; Gao A; Liu Y
Anticancer Drugs; 2021 Feb; 32(2):168-177. PubMed ID: 32826416
[TBL] [Abstract][Full Text] [Related]
13. Minichromosome maintenance protein 2 and 3 promote osteosarcoma progression via DHX9 and predict poor patient prognosis.
Cheng DD; Zhang HZ; Yuan JQ; Li SJ; Yang QC; Fan CY
Oncotarget; 2017 Apr; 8(16):26380-26393. PubMed ID: 28460433
[TBL] [Abstract][Full Text] [Related]
14. Bmi‑1‑targeting suppresses osteosarcoma aggressiveness through the NF‑κB signaling pathway.
Liu J; Luo B; Zhao M
Mol Med Rep; 2017 Dec; 16(6):7949-7958. PubMed ID: 28983587
[TBL] [Abstract][Full Text] [Related]
15. Multiple polymer architectures of human polyhomeotic homolog 3 sterile alpha motif.
Nanyes DR; Junco SE; Taylor AB; Robinson AK; Patterson NL; Shivarajpur A; Halloran J; Hale SM; Kaur Y; Hart PJ; Kim CA
Proteins; 2014 Oct; 82(10):2823-30. PubMed ID: 25044168
[TBL] [Abstract][Full Text] [Related]
16. MiR-384 Inhibits Malignant Biological Behavior Such as Proliferation and Invasion of Osteosarcoma by Regulating IGFBP3.
Tan Y; Chen L; Li S; Hao H; Zhang D
Technol Cancer Res Treat; 2020; 19():1533033820909125. PubMed ID: 32129151
[TBL] [Abstract][Full Text] [Related]
17. Micro-RNA 122 and micro-RNA 96 affected human osteosarcoma biological behavior and associated with prognosis of patients with osteosarcoma.
Liu B; Yao S; Zhou J
Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33078195
[TBL] [Abstract][Full Text] [Related]
18. COPS3 amplification and clinical outcome in osteosarcoma.
Yan T; Wunder JS; Gokgoz N; Gill M; Eskandarian S; Parkes RK; Bull SB; Bell RS; Andrulis IL
Cancer; 2007 May; 109(9):1870-6. PubMed ID: 17366602
[TBL] [Abstract][Full Text] [Related]
19. SIRT1-ZEB1-positive feedback promotes epithelial-mesenchymal transition process and metastasis of osteosarcoma.
Yu XJ; Guo XZ; Li C; Chong Y; Song TN; Pang JF; Shao M
J Cell Biochem; 2019 Mar; 120(3):3727-3735. PubMed ID: 30304565
[TBL] [Abstract][Full Text] [Related]
20. BMI1 is expressed in canine osteosarcoma and contributes to cell growth and chemotherapy resistance.
Shahi MH; York D; Gandour-Edwards R; Withers SS; Holt R; Rebhun RB
PLoS One; 2015; 10(6):e0131006. PubMed ID: 26110620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
